MedPath

Acupoint catgut embedding combined with hormone replacement therapy in the treatment of diminished ovarian reserve: A randomized controlled study

Phase 1
Recruiting
Conditions
diminished ovarian reserve
Registration Number
ITMCTR2000003762
Lead Sponsor
Shanghai Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria of traditional Chinese and Western medicine for ovarian reserve hypofunction;
2. Female patients 18 years old and younger than 40 years old;
3. Those who have signed an informed consent and can cooperate to complete the planned course of treatment;

Exclusion Criteria

1. Severe Kupperman syndrome score;
2. Patients with premature ovarian failure caused by drugs such as hormones and immunosuppressants;
3. Premature ovarian failure caused by bilateral or unilateral ovarian resection;
4. Combined with organic diseases of reproductive organs;
5. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system, and mental illness.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum sex hormone levels;
Secondary Outcome Measures
NameTimeMethod
Medical Outcomes Survey Short Form-36 (SF-36);Hamilton Rating Scale for Anxiety;Menstrual Condition Score Form;Antral follicle count;Kupperman Scale;Hamilton Rating Scale for Depression;
© Copyright 2025. All Rights Reserved by MedPath